MENU

YMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Y-mAbs Therapeutics (YMAB) Ownership - Who owns Y-mAbs Therapeutics?

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

391.22M

P/E Ratio

N/A

Total Cash

62.29M

Projected Growth

N/A

Total Debt

3.12M

Revenue

85.39M

Risk (Beta)

0.26

Dividend Yield

N/A

Total Cash/Share

1.37

Total Debt/Equity

N/A

Revenue/Share

1.90 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for YMAB

A.I. Advisor

published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile

Details

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com